Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
Following peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and...
主要な著者: | , , , , , |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2011
|
_version_ | 1826261377087438848 |
---|---|
author | Calvo, M Zhu, N Grist, J Ma, Z Loeb, J Bennett, D |
author_facet | Calvo, M Zhu, N Grist, J Ma, Z Loeb, J Bennett, D |
author_sort | Calvo, M |
collection | OXFORD |
description | Following peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and 4 receptors on microglia and stimulates proliferation, survival and chemotaxis of these cells. Here we studied the intracellular signaling pathways downstream of neuregulin-1-erbB activation in microglial cells. We found that neuregulin-1 in vitro induced phosphorylation of ERK1/2 and Akt without activating p38MAPK. Using specific kinase inhibitors we found that the mitogenic effect of neuregulin-1 on microglia was dependant on MEK/ERK1/2 pathway, the chemotactic effect was dependant on PI3K/Akt signaling and survival was dependant on both pathways. Intrathecal treatment with neuregulin-1 was associated with microgliosis and development of mechanical and cold pain related hypersensitivity which was dependant on ERK1/2 phosphorylation in microglia. Spinal nerve ligation results in a robust microgliosis and sustained ERK1/2 phosphorylation within these cells. This pathway is downstream of neuregulin-1/erbB signaling since its blockade resulted in a significant reduction in microglial ERK1/2 phosphorylation. Inhibition of the MEK/ERK1/2 pathway resulted in decreased spinal microgliosis and in reduced mechanical and cold hypersensitivity after peripheral nerve damage. We conclude that neuregulin-1 released after nerve injury activates microglial erbB receptors which consequently stimulates the MEK/ERK1/2 pathway that drives microglial proliferation and contributes to the development of neuropathic pain. |
first_indexed | 2024-03-06T19:20:26Z |
format | Journal article |
id | oxford-uuid:19e6fbe0-3b35-427b-a1e3-3d349155c7a3 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T19:20:26Z |
publishDate | 2011 |
record_format | dspace |
spelling | oxford-uuid:19e6fbe0-3b35-427b-a1e3-3d349155c7a32022-03-26T10:51:38ZFollowing nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:19e6fbe0-3b35-427b-a1e3-3d349155c7a3EnglishSymplectic Elements at Oxford2011Calvo, MZhu, NGrist, JMa, ZLoeb, JBennett, DFollowing peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and 4 receptors on microglia and stimulates proliferation, survival and chemotaxis of these cells. Here we studied the intracellular signaling pathways downstream of neuregulin-1-erbB activation in microglial cells. We found that neuregulin-1 in vitro induced phosphorylation of ERK1/2 and Akt without activating p38MAPK. Using specific kinase inhibitors we found that the mitogenic effect of neuregulin-1 on microglia was dependant on MEK/ERK1/2 pathway, the chemotactic effect was dependant on PI3K/Akt signaling and survival was dependant on both pathways. Intrathecal treatment with neuregulin-1 was associated with microgliosis and development of mechanical and cold pain related hypersensitivity which was dependant on ERK1/2 phosphorylation in microglia. Spinal nerve ligation results in a robust microgliosis and sustained ERK1/2 phosphorylation within these cells. This pathway is downstream of neuregulin-1/erbB signaling since its blockade resulted in a significant reduction in microglial ERK1/2 phosphorylation. Inhibition of the MEK/ERK1/2 pathway resulted in decreased spinal microgliosis and in reduced mechanical and cold hypersensitivity after peripheral nerve damage. We conclude that neuregulin-1 released after nerve injury activates microglial erbB receptors which consequently stimulates the MEK/ERK1/2 pathway that drives microglial proliferation and contributes to the development of neuropathic pain. |
spellingShingle | Calvo, M Zhu, N Grist, J Ma, Z Loeb, J Bennett, D Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. |
title | Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. |
title_full | Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. |
title_fullStr | Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. |
title_full_unstemmed | Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. |
title_short | Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway. |
title_sort | following nerve injury neuregulin 1 drives microglial proliferation and neuropathic pain via the mek erk pathway |
work_keys_str_mv | AT calvom followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway AT zhun followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway AT gristj followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway AT maz followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway AT loebj followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway AT bennettd followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway |